Enhancer methylation dynamics contribute to cancer plasticity and patient mortality. - Test2 - elhamkhani - TriplyDB

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

http://www.wikidata.org/entity/Q36893810

about

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.Potential energy landscapes identify the information-theoretic nature of the epigenome.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.Epigenetic plasticity and the hallmarks of cancer.Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.Integrative analysis to identify oncogenic gene expression changes associated with copy number variations of enhancer in ovarian cancer.Dynamic epigenomic landscapes during early lineage specification in mouse embryos.SIRT1 regulates Mxd1 during malignant melanoma progression.Orphan CpG islands define a novel class of highly active enhancers.The Unforeseen Non-Coding RNAs in Head and Neck Cancer.DNA methylation in urothelial carcinoma.Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer.MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.The contributions of cancer cell metabolism to metastasis Modulation of mitochondrial DNA copy number in a model of glioblastoma induces changes to DNA methylation and gene expression of the nuclear genome in tumours Meta-Analysis of Genome-Wide Association Studies Identifies Novel Functional CpG-SNPs Associated with Bone Mineral Density at Lumbar Spine

P2860

Q37737945-B968224B-632C-43B6-931B-84A4CC887143 Q38383659-DB033356-D682-4F6C-B00F-48763067D835 Q38873928-56C47D7E-F55A-4E98-B6C8-4565F35149BE Q38997020-E7E30EAB-1ABB-432F-82FC-D223575A18BE Q39197388-7814000F-75F2-4433-9917-448962882FD6 Q39282288-F5B950E1-1D35-4546-938A-1424E3CD3BA1 Q39448979-0156E03A-1DD6-463F-8B0A-647EB95F84A4 Q41280310-85E23E90-8143-4561-BC31-A735F1441D31 Q47124134-B7337590-D2C6-47E5-92FF-F2C92A859352 Q47281433-6888FDDF-1C11-459C-9E31-C8283592F87E Q49569717-08606030-738F-4996-A040-4302268CCECC Q51032114-3DD7419E-B16C-4DEC-8587-60AFBF6A9F00 Q52729619-0ADF875B-FC81-43D5-B8D5-0789A8273FB7 Q53691833-3599768C-7E6E-4536-AE18-565D2A6AA40C Q54941043-42817828-A87A-4CD6-ADF4-A46651C7CF4C Q55236735-71172CD7-D4A6-4C25-9402-D481D69209AD Q57188839-5F9CF51C-F209-4961-AC16-20A2B108EA65 Q58747194-544A7E6C-9559-49AE-940F-4B4FB4375547 Q58796982-4E24A3FB-96B1-4159-A805-8294FB55DC61

P2860

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

http://www.wikidata.org/entity/Q36893810

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

@en

type

label

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

@en

prefLabel

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

@en

P1433

Q36893810-1E3D2A86-1B97-46A6-8EAB-FC54DDBF83C1

P1476

Q36893810-30D4EBE9-6A6D-4C2B-B777-CB33D2559616

P2093

Q36893810-0B3276AD-0718-4756-AF22-76FF30D861FF

Q36893810-2DBE8CB2-BBDF-474F-99E5-70DBACE7EE13

Q36893810-50F03EE6-0F04-4665-9815-9BDA7E3A3065

Q36893810-520C7C0E-1594-441D-B6C3-2D5FCADE0293

Q36893810-5D1E9F98-DEC5-40F0-8704-0DABD7507F1B

Q36893810-604DD68E-E922-4F33-89C9-3438F55649CA

Q36893810-67E689B5-4CAE-4363-9345-A49138957019

Q36893810-86B8C26D-BBE5-418A-A28B-D375BCB8D3E2

Q36893810-90CEE83F-C759-476F-AF6E-0ED67118C378

Q36893810-E431FB33-813B-4DF0-A79A-31671FA2C673

P2860

Q36893810-03F64E34-BA0B-4E55-B2BA-B67BAAC4AF55

Q36893810-177EE8F6-E88A-486B-A810-3DA2BE15A9E9

Q36893810-1CA41F41-FF83-44F6-A041-41ADEBCAE69A

Q36893810-1F7C8994-43CA-404E-9BA0-63A32C1486D5

Q36893810-20790FB7-6F4C-4C64-BC6E-4E8158592523

Q36893810-26F7DB46-2B8B-425F-B746-3FC64E3ABC90

Q36893810-27995188-2D29-4C23-91AB-FC276ADF40B8

Q36893810-2AB26488-09B4-4EE7-8E87-935AF0FC20FA

Q36893810-32A140C9-CCD9-4436-9323-8E1BEE118322

Q36893810-3826DE6A-8C97-4690-91B8-863D79B9CC2B

P304

Q36893810-611262BE-A7A1-42A9-A510-94A6D05EAA61

P31

Q36893810-D6484F0A-2200-4610-90D8-AD72D1C3A07D

P356

Q36893810-0724CD46-655B-46DE-9738-BDE33AC38D23

P433

Q36893810-52B3496F-3A42-4646-89B4-96C15447F0A1

P478

Q36893810-74B857F5-78C3-412B-AB30-FEFAEBFBDE04

P50

Q36893810-12142D25-ECBE-4828-A549-76B7D00AF6AF

P577

Q36893810-74E40839-2563-422C-9F5D-BA013D83BA9A

P698

Q36893810-2678164B-5673-4DFE-A2B3-A47B6B586402

P921

Q36893810-C050D3B9-5233-482B-AF9E-45A900D43133

P932

Q36893810-730B658F-397D-46A3-86E5-DF8DE8B923D0

P356

P1433

Genome Research

P1476

Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

@en

P2093

Avi Salamon

http://www.w3.org/2001/XMLSchema#string

Carmit Levy

http://www.w3.org/2001/XMLSchema#string

Danna Sheinboim

http://www.w3.org/2001/XMLSchema#string

David Amar

http://www.w3.org/2001/XMLSchema#string

Hagar Malcov

http://www.w3.org/2001/XMLSchema#string

Rachel E Bell

http://www.w3.org/2001/XMLSchema#string

Ron Shamir

http://www.w3.org/2001/XMLSchema#string

Sahar Gelfman

http://www.w3.org/2001/XMLSchema#string

Tamar Golan

http://www.w3.org/2001/XMLSchema#string

Tamar Liron

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Enhancer RNAs and regulated transcriptional programs

Cancer invasion and the microenvironment: plasticity and reciprocity

4DGenome: a comprehensive database of chromatin interactions.

Histone modifications at human enhancers reflect global cell-type-specific gene expression

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

ENCODE data in the UCSC Genome Browser: year 5 update

Super-enhancers in the control of cell identity and disease

Functions of DNA methylation: islands, start sites, gene bodies and beyond

P304

601-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/GR.197194.115

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26907635

http://www.w3.org/2001/XMLSchema#string

P921

P932

4864467

http://www.w3.org/2001/XMLSchema#string